AR and Familial prostate cancer: While we propose that expression of these factors is induced as a result of developing tumor hypoxia, it is interesting to note the recent characterization of AR-mediated repression of IL8 gene transcription in prostate cancer cell models, indicating that sustained AR inhibition arising from enzalutamide treatment may also directly contribute to increased IL8 production (23).